$BSX

Boston Scientific cyberattack disrupts global operations, shipments

Boston Scientific reported a cyberattack on August 25, disrupting global operations and order processing. The impact is still unknown, and the company's stock fell 5.8% in premarket trading. Earlier, the company cut its full-year 2026 adjusted earnings per share forecast to $3.28-$3.32 and reduced organic sales growth outlook to 5%-6%. Second-quarter results exceeded expectations, with adjusted EPS of $0.86 on net sales of $5.44 billion.

Original reporting
Published Aug 28, 2026, 1:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 1:18 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Boston Scientific cyberattack disrupts global operations, shipments — source image
Decision brief

The 30-second read

$BSXBearishHigh
01

Why it matters

The incident caused a 5.8% pre‑market drop, raising concerns about supply chain continuity and earnings outlook.

02

Market read

First report of a material cyber event affecting a large‑cap med‑tech firm, with immediate price impact.

03

What to watch

Insurance coverage and potential regulatory fines could mitigate or exacerbate the financial hit.

Relevance 7/10Novelty 8/10Timing: premarket today

Background

Boston Scientific announced a cyberattack that began on Aug 25, disrupting order processing and shipments.

Company-level read

Ticker impact

$BSXBearishHigh confidence
Context

Cyberattack disrupts global operations and triggers a 5.8% pre‑market decline in Boston Scientific stock.

Expected impact

Further short‑term downside as the company assesses material impact.

Evidence & confidence

First‑hand disclosure of a cyber incident with a measurable pre‑market move; no prior public reporting.

Market effects

Medical device sector may see heightened risk perception and tighter cybersecurity scrutiny.

U.S. healthcare stocks could face short‑term volatility.

Potential ripple to global med‑tech supply chains if the breach spreads.

Counterpoint

If the attack is contained quickly, the stock may rebound, offering a buying opportunity on the dip.

Key entities

  • Boston Scientific

    Medical device manufacturer (ticker BSX).

Related articles

$BSXMed

Boston Scientific Cyberattack Halts Shipments: Weeks of Device Delays Threaten Hospital Supply

Boston Scientific Corporation experienced a cyberattack on August 25, disrupting order-processing and shipping systems for medical devices. The company, with $20.1B in 2025 revenue, filed an 8-K with the SEC. Analysts estimate up to three weeks of delays, similar to a 2026 Stryker attack. No ransomware group has claimed responsibility, and no restoration timeline has been set.

$BSXMed

Boston Scientific Says a Cyberattack Has Disrupted Systems Used to Process and Ship Medical Device Orders

Boston Scientific reported a cyberattack on August 25 disrupted its IT systems, impacting order processing and shipping. The company engaged experts to investigate and has not yet determined the material impact. Shares fell about 5% following the disclosure. The incident does not affect implanted devices, but hospitals may face supply delays. The full scope and timeline for restoration remain unknown.

$BSXMed

Boston Scientific Cyberattack Stalls Cardiac Device Supply Chain for Hospitals

Boston Scientific's operations were disrupted by a cyberattack, halting supply of critical medical devices. The company filed an SEC 8-K disclosure, and analysts estimate a 600-700 basis point impact on Q3 revenue. The stock fell 3.38% on August 26, compounded by a concurrent product recall. The company is at least the ninth medtech firm hit by a cyberattack in 2026.

$BSXLow

Boston Scientific Suffers Global Disruption After Cyber Incident

Boston Scientific reported a cyber incident on August 25, causing global IT disruptions and halting order processing. The company is working to restore systems with third-party experts, but the timeline is uncertain. Boston Scientific is a major medical device manufacturer with $20bn in net sales. Recent cyber-attacks have also targeted other medtech firms like Medtronic, iRhythm, and Abbott Laboratories.